Vectorious Medical Technologies, a Tel-Aviv based company, has developed the V-LAP™, a miniature wireless pressure sensor implanted into the heart’s left atrium.  The V-LAP™ enables patients to take a direct daily measurement of the heart’s left atrial pressure (LAP), the earliest and most accurate indicator of heart function, and therefore to optimize treatment at an early enough stage to prevent decompensation. As a result, patients will enjoy an enhanced quality of life, physicians will be able to provide superior care and hospitals will see fewer readmissions, saving the healthcare system billions per annum.

Go to website: